Véronique Stoven

ORCID: 0000-0003-0828-0759
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Computational Drug Discovery Methods
  • Protein Structure and Dynamics
  • Cystic Fibrosis Research Advances
  • Machine Learning in Materials Science
  • Bioinformatics and Genomic Networks
  • Gene expression and cancer classification
  • Carbohydrate Chemistry and Synthesis
  • Neonatal Respiratory Health Research
  • Biochemical and Molecular Research
  • Lysosomal Storage Disorders Research
  • Enzyme Structure and Function
  • Chemical Synthesis and Analysis
  • Machine Learning in Bioinformatics
  • Drug Transport and Resistance Mechanisms
  • Receptor Mechanisms and Signaling
  • Phagocytosis and Immune Regulation
  • Advanced NMR Techniques and Applications
  • Legume Nitrogen Fixing Symbiosis
  • Molecular spectroscopy and chirality
  • Monoclonal and Polyclonal Antibodies Research
  • Calcium Carbonate Crystallization and Inhibition
  • Molecular Biology Techniques and Applications
  • Gene Regulatory Network Analysis
  • Pharmacogenetics and Drug Metabolism
  • Glycogen Storage Diseases and Myoclonus

Université Paris Sciences et Lettres
2016-2025

Inserm
2015-2025

Institut Curie
2015-2025

École Nationale Supérieure des Mines de Paris
2014-2024

ParisTech
2017-2019

Cancer et génome: Bioinformatique, biostatistiques et épidémiologie des systèmes complexes
2017

Génomique Bioinformatique et Applications
2017

Kyushu University
2012

Kyoto University
2012

Kyoto University Institute for Chemical Research
2012

Abstract Background Drug side-effects, or adverse drug reactions, have become a major public health concern. It is one of the main causes failure in process development, and withdrawal once they reached market. Therefore, silico prediction potential side-effects early discovery process, before reaching clinical stages, great interest to improve this long expensive provide new efficient safe therapies for patients. Results In present work, we propose method predict candidate molecules based...

10.1186/1471-2105-12-169 article EN cc-by BMC Bioinformatics 2011-05-18

Abstract Motivation: Identifying the emergence and underlying mechanisms of drug side effects is a challenging task in development process. This underscores importance system–wide approaches for linking different scales actions; namely drug-protein interactions (molecular scale) (phenotypic toward effect prediction uncharacterized drugs. Results: We performed large-scale analysis to extract correlated sets targeted proteins effects, based on co-occurrence drugs protein-binding profiles...

10.1093/bioinformatics/bts383 article EN cc-by Bioinformatics 2012-09-03
Federica Eduati Lara M. Mangravite Tao Wang Jing Tang J Christopher Bare and 95 more Rui Huang Thea Norman Mike Kellen Michael P. Menden Yang Yang Xiaowei Zhan Rui Zhong Guanghua Xiao Menghang Xia Nour Abdo Oksana Kosyk Stephen Friend Gustavo Stolovitzky Allen Dearry Raymond R. Tice Anton Simeonov Ivan Rusyn Fred A. Wright Yang Xie Salvatore Alaimo Alicia Amadoz Muhammad Ammad-ud-din Chloé‐Agathe Azencott Jaume Bacardit Pelham Barron Elsa Bernard Andreas Beyer Bin Shao Alena van Bömmel Karsten Borgwardt April M. Brys Brian E. Caffrey Jeffrey Chang Jungsoo Chang Eleni Christodoulou Mathieu Clément‐Ziza Trevor Cohen Marianne Cowherd Sofie Demeyer Joaquı́n Dopazo Joel D Elhard André O. Falcão Alfredo Ferro David A. Friedenberg Rosalba Giugno Yunguo Gong Jenni Gorospe Courtney A. Granville Dominik G. Grimm Matthias Heinig Rosa Hernansaiz-Ballesteros Sepp Hochreiter Hua Huang Matthew R. Huska Yunlong Jiao Günter Klambauer Michael Kuhn Miron B. Kursa Rintu Kutum Nicola Lazzarini Inhan Lee Michael K. K. Leung Weng Khong Lim C. Liu Felipe Llinares López Alessandro Mammana Andreas Mayr Tom Michoel Misael Mongiovı̀ Jonathan D. Moore R. Narasimhan Stephen O. Opiyo Gaurav Pandey Andrea L. Peabody Juliane Perner Alfredo Pulvirenti Konrad Rawlik Susanne Reinhardt Carol G Riffle Douglas M. Ruderfer Aaron Sander Richard S. Savage Erwan Scornet Patricia Sebastián-León Roded Sharan Carl Johann Simon-Gabriel Véronique Stoven Jingchun Sun Ana Lúcia Teixeira Albert Tenesa Jean‐Philippe Vert Martin Vingron Thomas Walter Sean Whalen Zofia Wiśniewska

When it becomes completely possible for one to computationally forecast the impacts of harmful substances on humans, would be easier attempt addressing shortcomings existing safety testing chemicals. In this paper, we relay outcomes a community-facing DREAM contest prognosticate nature environment-based compounds, considering their likelihood have disadvantageous health-related effects human populace. Our research quantified cytotoxicity levels in 156 compounds across 884 lymphoblastic lines...

10.18034/ajhal.v4i2.577 article EN cc-by-nc Asian Journal of Humanity Art and Literature 2017-12-31

The G-protein coupled receptor (GPCR) superfamily is currently the largest class of therapeutic targets. In silico prediction interactions between GPCRs and small molecules in transmembrane ligand-binding site therefore a crucial step drug discovery process, which remains daunting task due to difficulty characterize 3D structure most GPCRs, limited amount known ligands for some members superfamily. Chemogenomics, attempts all target simultaneously, has recently been proposed as an...

10.1186/1471-2105-9-363 article EN cc-by BMC Bioinformatics 2008-09-06

Drug effects are mainly caused by the interactions between drug molecules and their target proteins including primary targets off-targets. Identification of molecular mechanisms behind overall drug-target is crucial in design process.We develop a classifier-based approach to identify chemogenomic features (the underlying associations chemical substructures protein domains) that involved interaction networks. We propose novel algorithm for extracting informative using L(1) regularized...

10.1093/bioinformatics/bts412 article EN cc-by Bioinformatics 2012-09-03

Predicting which molecules can bind to a given binding site of protein with known 3D structure is important decipher the function, and useful in drug design. A classical assumption structural biology that proteins similar structures have related molecular functions, therefore may ligands. However, do not display any overall sequence or similarity also ligands if they contain sites. Quantitatively assessing between sites be propose new for pocket, based on those pockets.We method quantify...

10.1186/1471-2105-11-99 article EN cc-by BMC Bioinformatics 2010-02-22
Solveig K. Sieberts Fan Zhu Javier Garcı́a-Garcı́a Eli A. Stahl Abhishek Pratap and 95 more Gaurav Pandey Dimitrios A. Pappas Daniel Aguilar Bernat Anton Jaume Bonet Ridvan Eksi Oriol Fornés Emre Güney Hongdong Li Manuel Alejandro Marín-López Bharat Panwar Joan Planas-Iglesias Daniel Poglayen Jing Cui André O. Falcão Christine Suver Bruce Hoff Venkat S. K. Balagurusamy Donna Dillenberger Elias Chaibub Neto Thea Norman Tero Aittokallio Muhammad Ammad-ud-din Chloé‐Agathe Azencott Víctor Bellón Valentina Boeva Kerstin Bunte Himanshu Chheda Lu Cheng Jukka Corander Michel Dumontier Anna Goldenberg Peddinti Gopalacharyulu Mohsen Hajiloo Daniel Hidru Alok Jaiswal Samuel Kaski Beyrem Khalfaoui Suleiman A. Khan Eric R. Kramer Pekka Marttinen Aziz M. Mezlini Bhuvan Molparia Matti Pirinen Janna Saarela Matthias Samwald Véronique Stoven Hao Tang Jing Tang Ali Torkamani Jean-Phillipe Vert Bo Wang Tao Wang Krister Wennerberg Nathan E. Wineinger Guanghua Xiao Yang Xie Rae S. M. Yeung Xiaowei Zhan Cheng Zhao Manuel Calaza Haitham Elmarakeby Lenwood S. Heath Quan Long Jonathan D. Moore Stephen O. Opiyo Richard S. Savage Jun Zhu Jeff Greenberg Joel Kremer Kaleb Michaud Anne Barton Marieke J. H. Coenen Xavier Mariette Corinne Miceli‐Richard Nancy A. Shadick Michael E. Weinblatt Niek de Vries Paul P. Tak Daniëlle M. Gerlag T. Huizinga Fina Kurreeman Cornelia F Allaart S. Louis Bridges Lindsey A. Criswell Larry W. Moreland Lars Klareskog Saedís Saevarsdóttir Leonid Padyukov Peter K. Gregersen Stephen Friend Robert Plenge Gustavo Stolovitzky Baldo Oliva Yuanfang Guan

Rheumatoid arthritis (RA) affects millions world-wide. While anti-TNF treatment is widely used to reduce disease progression, fails in ∼one-third of patients. No biomarker currently exists that identifies non-responders before treatment. A rigorous community-based assessment the utility SNP data for predicting efficacy RA patients was performed context a DREAM Challenge (http://www.synapse.org/RA_Challenge). An open challenge framework enabled comparative evaluation predictions developed by...

10.1038/ncomms12460 article EN cc-by Nature Communications 2016-08-23

The identification of rules governing molecular recognition between drug chemical substructures and protein functional sites is a challenging issue at many stages the development process. In this paper we develop novel method to extract sets domains that govern drug-target interactions on genome-wide scale. This made possible using sparse canonical correspondence analysis (SCCA) for analyzing substructure profiles domain simultaneously. does not depend availability 3D structures. From data...

10.1021/ci100476q article EN Journal of Chemical Information and Modeling 2011-04-21

A conformational study of the double‐stranded decanucleotide d(GCCG * G ATCGC) · d(GCGATCCGGC), with guanines chelating a cis ‐Pt(NH 3 ) 2 moiety, has been accomplished using 1 H and 31 P NMR, molecular mechanics. Correlation NMR data models disclosed an equilibrium between several kinked conformations ruled out unkinked structure. The deformation is localized at CG CCG trinucleotide where helix by approximately 60° towards major groove unwound 12–19°. revealed unexpected mobility cytosine...

10.1111/j.1432-1033.1990.tb19435.x article EN European Journal of Biochemistry 1990-11-01

Cystic fibrosis is characterized by chronic inflammation and an imbalance in the concentrations of alveolar lung oxidants antioxidants, which result cell damage. Modifications glutathione are recognized as a salient feature inflammatory diseases such cystic fibrosis, plays major role protection against oxidative stress important modulation apoptosis. The transmembrane conductance regulator (CFTR) permeable to Cl<sup>−</sup>, larger organic ions, reduced oxidized forms glutathione, ΔF508 CFTR...

10.1074/jbc.m110288200 article EN cc-by Journal of Biological Chemistry 2002-08-01

We introduce a family of positive definite kernels specifically optimized for the manipulation 3D structures molecules with kernel methods. The are based on comparison three-point pharmacophores present in molecules, set molecular features known to be particularly relevant virtual screening applications. computationally demanding exact implementation these kernels, as well fast approximations related classical fingerprint-based approaches. Experimental results suggest that this new approach...

10.1021/ci060138m article EN Journal of Chemical Information and Modeling 2006-08-12

Cancer driver genes, i.e., oncogenes and tumor suppressor are involved in the acquisition of important functions tumors, providing a selective growth advantage, allowing uncontrolled proliferation avoiding apoptosis. It is therefore to identify these both for fundamental understanding cancer help finding new therapeutic targets or biomarkers. Although most frequently mutated genes have been identified, it believed that many more remain be discovered, particularly specific some types. In this...

10.1371/journal.pcbi.1007381 article EN cc-by PLoS Computational Biology 2019-09-30

Abstract Chemogenomics, also called proteochemometrics, covers a range of computational methods that can be used to predict protein–ligand interactions at large scales in the protein and chemical spaces. They differ from more classical ligand-based (also QSAR) ligands for given receptor. In context drug discovery process, chemogenomics allows tackle question predicting off-target proteins candidates, one main causes undesirable side-effects failure within drugs development processes. The...

10.1186/s13321-020-0413-0 article EN cc-by Journal of Cheminformatics 2020-02-10

Abstract The challenges of drug discovery from hit identification to clinical development sometimes involves addressing scaffold hopping issues, in order optimise molecular biological activity or ADME properties, mitigate toxicology concerns a candidate. Docking is usually viewed as the method choice for isofunctional molecules, i. e. highly dissimilar molecules that share common binding modes with protein target. However, structure may not be suitable docking because low resolution, even...

10.1002/minf.202400159 article EN Molecular Informatics 2025-03-01

Abstract Identification of novel chemotypes with biological activity similar to a known active molecule is an important challenge in drug discovery called ‘scaffold hopping’. Small‐, medium‐, and large‐step scaffold hopping efforts may lead increasing degrees chemical structure novelty respect the parent compound. In present paper, we focus on problem hopping. We assembled high quality well characterized dataset examples comprising pairs molecules including variety protein targets. This was...

10.1002/minf.202200216 article EN cc-by-nc-nd Molecular Informatics 2023-01-12

Lithostathine (pancreatic stone protein, Reg protein) is, in addition to albumin, the major nonenzymatic protein of pancreatic juice. It has been assumed inhibit calcium carbonate precipitation and therefore prevent formation ducts. This function however, debatable. The assumption is based on inhibition <i>in vitro</i> crystal nucleation growth by lithostathine. Considering that these phenomena occur only under certain critical conditions, we re-examined question using a preparation where...

10.1074/jbc.273.9.4967 article EN cc-by Journal of Biological Chemistry 1998-02-01

Cystic fibrosis is caused by mutations in the cystic transmembrane conductance regulator (CFTR) gene. The most frequent mutation deletion of F508 first nucleotide binding fold (NBF1). It induces a perturbation folding NBF1, which impedes posttranslational maturation CFTR. Determination three‐dimensional structure NBF1 would help to understand this defect. We present novel model for built from crystal bovine mitochondrial F 1 ‐ATPase protein. This gives reasonable interpretation effect on...

10.1016/s0014-5793(97)00363-3 article EN FEBS Letters 1997-05-05

Identification of the protein targets hit molecules is essential in drug discovery process. Target prediction with machine learning algorithms can help accelerate this search, limiting number required experiments. However, Drug-Target Interactions databases used for training present high statistical bias, leading to a false positives, thus increasing time and cost experimental validation campaigns. To minimize positives among predicted targets, we propose new scheme choosing negative...

10.3390/ijms22105118 article EN International Journal of Molecular Sciences 2021-05-12
Coming Soon ...